ROCCHETTI, MARCELLA
 Distribuzione geografica
Continente #
NA - Nord America 7.176
EU - Europa 4.564
AS - Asia 3.487
SA - Sud America 501
AF - Africa 49
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 2
Totale 15.791
Nazione #
US - Stati Uniti d'America 6.969
SG - Singapore 1.294
IT - Italia 1.030
DE - Germania 986
CN - Cina 918
RU - Federazione Russa 523
HK - Hong Kong 429
BR - Brasile 404
VN - Vietnam 402
SE - Svezia 381
IE - Irlanda 293
PL - Polonia 287
GB - Regno Unito 257
UA - Ucraina 193
FR - Francia 174
CA - Canada 149
AT - Austria 116
FI - Finlandia 98
IN - India 98
DK - Danimarca 60
KR - Corea 60
ID - Indonesia 59
TR - Turchia 59
NL - Olanda 52
JP - Giappone 46
AR - Argentina 44
MX - Messico 39
BE - Belgio 28
BD - Bangladesh 27
ZA - Sudafrica 24
EC - Ecuador 19
ES - Italia 19
IQ - Iraq 17
PK - Pakistan 13
BG - Bulgaria 12
CH - Svizzera 11
LT - Lituania 11
EU - Europa 9
IR - Iran 9
CO - Colombia 8
TW - Taiwan 8
CZ - Repubblica Ceca 7
JO - Giordania 7
MA - Marocco 7
VE - Venezuela 7
PT - Portogallo 6
UY - Uruguay 6
UZ - Uzbekistan 6
CL - Cile 5
MY - Malesia 5
AE - Emirati Arabi Uniti 4
DO - Repubblica Dominicana 4
EG - Egitto 4
IL - Israele 4
KE - Kenya 4
PY - Paraguay 4
RO - Romania 4
AZ - Azerbaigian 3
BB - Barbados 3
CR - Costa Rica 3
NO - Norvegia 3
NP - Nepal 3
PA - Panama 3
PE - Perù 3
PH - Filippine 3
SA - Arabia Saudita 3
SC - Seychelles 3
AO - Angola 2
AU - Australia 2
BH - Bahrain 2
HU - Ungheria 2
KZ - Kazakistan 2
LV - Lettonia 2
NI - Nicaragua 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
CI - Costa d'Avorio 1
DZ - Algeria 1
GR - Grecia 1
HN - Honduras 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
Totale 15.791
Città #
Ann Arbor 1.270
Singapore 816
Ashburn 685
Frankfurt am Main 606
Woodbridge 528
Wilmington 452
Hong Kong 423
Fairfield 411
Chandler 345
Milan 341
Houston 327
Dublin 288
Kraków 263
Seattle 185
Jacksonville 179
Dearborn 171
New York 165
Beijing 156
Cambridge 148
Dallas 130
Santa Clara 130
Los Angeles 123
Hefei 118
Vienna 109
Ho Chi Minh City 98
Princeton 91
Dong Ket 80
Nanjing 73
Shanghai 73
Hanoi 61
Buffalo 58
Seoul 53
Jakarta 50
Chicago 49
Lawrence 41
Helsinki 40
São Paulo 40
Moscow 39
Munich 39
The Dalles 36
Altamura 33
Toronto 32
Lachine 31
Brussels 28
Montréal 28
Torino 27
Nanchang 26
Council Bluffs 25
Fremont 25
Guangzhou 25
Denver 24
Tokyo 24
San Diego 23
Boardman 21
London 21
Montreal 21
Warsaw 20
Zhengzhou 20
Turin 19
Nuremberg 18
Rome 18
Columbus 17
Hyderabad 17
Poplar 17
Shenyang 17
Orem 16
Rio de Janeiro 16
Sanayi 16
Ankara 15
Brooklyn 15
Jiaxing 15
Jinan 15
Changsha 14
Chennai 14
Stockholm 14
Andover 13
Falls Church 13
Haiphong 13
Hebei 13
Huizen 13
Ottawa 13
Tianjin 13
Atlanta 12
Boston 12
Manchester 12
Pune 12
Turku 12
Verona 12
Da Nang 11
Florence 11
Kunming 11
Mexico City 11
Monza 11
Phoenix 11
Como 10
Edmonton 10
Johannesburg 10
Kent 10
Lappeenranta 10
Memphis 10
Totale 10.306
Nome #
Late sodium current and intracellular ionic homeostasis in acute ischemia 432
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 427
Respiratory metabolism and calorie restriction relieve persistent endoplasmic reticulum stress induced by calcium shortage in yeast 422
MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes 418
Action potential contour contributes to species differences in repolarization response to b-adrenergic stimulation 415
Targeting GRP receptor: design, synthesis and preliminary biological characterization of new non-peptide antagonists of bombesin 405
NOS1AP polymorphisms reduce NOS1 activity and interact with prolonged repolarization in arrhythmogenesis 370
Istaroxime Metabolite PST3093 Selectively Stimulates SERCA2a and Reverses Disease-Induced Changes in Cardiac Function 361
Prevention of myocardial remodeling by chronic INaL blockade in pulmonary hypertension 353
Calcium store stability as an antiarrhythmic endpoint 341
Caffeine-induced Ca(2+) signaling as an index of cardiac progenitor cells differentiation 336
Marine n-3 PUFAs modulate IKs gating, channel expression, and location in membrane microdomains 336
Late sodium current (INaL) in pancreatic β-cells 334
Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension 330
CD14 regulates the dendritic cell life cycle after LPS exposure through NFAT activation 323
Tissue specificity of mitochondrial adaptations in rats after 4 weeks of normobaric hypoxia 319
Altered functional differentiation of mesoangioblasts in a genetic myopathy 318
Human iPSC modeling of a familial form of atrial fibrillation reveals a gain of function of If and ICaL in patient-derived cardiomyocytes 318
Human induced pluripotent stem cells derived from a cardiac somatic source: insights for an in-vitro cardiomyocyte platform 312
Highly Selective SERCA2a Activators: Preclinical Development of a Congeneric Group of First-in-Class Drug Leads against Heart Failure 312
A Brugada syndrome mutation (p.S216L) and its modulation by p.H558R polymorphism: standard and dynamic characterization 306
SERCA2a stimulation by istaroxime improves intracellular Ca2+ handling and diastolic dysfunction in a model of diabetic cardiomyopathy 302
Aberrant Functional Differentiation of Cardiac Precursors from a Dystrophic Mouse 298
Combination of miRNA499 and miRNA133 exerts a synergic effect on cardiac differentiation 298
Modulation of sarcoplasmic reticulum function by istaroxime (PST2744) in a pressure-overload heart failure model 295
Interstitial pressure and lung oedema in chronic hypoxia 293
Role and mechanism of subcellular Ca2+ distribution in the action of two inotropic agents with different toxicity 287
IKr Impact on Repolarization and Its Variability Assessed by Dynamic Clamp 286
Role of the β3-adrenergic receptor subtype in catecholamine-induced myocardial remodeling 286
Peptidomimetic Targeting of Cavβ2 Overcomes Dysregulation of the L-Type Calcium Channel Density and Recovers Cardiac Function 282
Modulation of sarcoplasmic reticulum function by Na+/K+ pump inhibitors with different toxicity: digoxin and PST2744 [(E,Z)-3-((2-aminoethoxy)imino)androstane-6,17-dione hydrochloride]. 277
Liraglutide preserves CD34+ stem cells from dysfunction Induced by high glucose exposure 275
Modulation of sympathetic activity and heart rate variability by ivabradine 269
A variant in the carboxyl-terminus of connexin 40 alters GAP junctions and increases risk for tetralogy of Fallot 263
Rate dependency of beta-adrenergic modulation of repolarizing currents in the guinea-pig ventricle 260
Stress-induced premature senescence is associated with a prolonged QT interval and recapitulates features of cardiac aging 242
The role of the autonomic system in rate-dependent repolarization changes 232
The late Na+ current--origin and pathophysiological relevance 232
Pharmacological profile of the novel inotropic agent (E,Z)-3-((2-aminoethoxy)imino)androstane-6,17-dione hydrochloride (PST2744) 222
Intracellular Ca2+ dynamics in isolated Vascular Smooth Muscle Cells (VSMCs) from rat distal pulmonary artery through a non enzimatic method 221
Ranolazine ameliorates postresuscitation electrical instability and myocardial dysfunction and improves survival with good neurologic recovery in a rat model of cardiac arrest 221
Diverse toxicity associated with cardiac Na+/K+ pump inhibition: Evaluation of electrophysiological mechanisms 206
Identification and functional characterisation of a new KCNJ2 mutation 206
Fisiologia normale e patologia dell'atrio 205
Regulation of the sinoatrial pacemaker. Selective If inhibition by ivabradine 205
Structural and Electrophysiological Changes in a Model of Cardiotoxicity Induced by Anthracycline Combined With Trastuzumab 205
Istaroxime metabolite PST3093 selectively stimulates SERCA2a and reverses disease-induced changes in cardiac function 201
A dynamic clamping approach using in silico IK1 current for discrimination of chamber-specific hiPSC-derived cardiomyocytes 191
Mechanisms of beta-adrenergic modulation of I(Ks) in the guinea-pig ventricle: insights from experimental and model-based analysis 191
Selective SERCA2a activator as a candidate for chronic heart failure therapy 182
Generation and characterization of the human induced pluripotent stem cell (hiPSC) line NCUFi001-A from a patient carrying KCNQ1 G314S mutation 179
Striatin knock out induces a gain of function of INa and impaired Ca2+ handling in mESC‐derived cardiomyocytes 176
Istaroxime follow-on compounds: A new class of selective SERCA2a activators for chronic heart failure treatment 165
Intracellular Ca2+ dynamics modulation by istaroxime and its metabolite in pulmonary artery smooth muscle cells. 165
Recombinant hSERCA2a in yeast microsomes: a new tool for mechanistic studies on drug-induced SERCA2a stimulation 144
In-vitro studies of the NaV1.5 S805L Brugada mutation: The resting cell voltage is a critical element in determining the pathological or physiological phenotype of the current 139
SERCA2a stimulation by istaroxime improves intracellular Ca2+ handling and diastolic dysfunction in a model of diabetic cardiomyopathy (DCM) 138
The long-lasting istaroxime metabolite PST3093 stimulates SERCA2a and reverses disease-induced changes in cardiac function 137
Human Induced Pluripotent Stem Cells-Derived Cardiomyocytes Carrying CALM1-F142l Mutation Recapitulate LQTS Phenotype in Vitro 123
INTRACELLULAR Ca 2+ DYNAMICS MODULATION BY ISTAROXIME AND ITS METABOLITE IN PULMONARY ARTERY SMOOTH MUSCLE CELLS 112
Hypokalemia and bradycardia unmask the loss-of-function phenotype of a Brugada Syndrome SCN5A mutation 72
YAP1 reactivation in cardiomyocytes following ECM remodelling contributes to the development of contractile force and sarcomere maturation 25
Development of Small-molecule SERCA2a Stimulators: A Novel Class of Ino-lusitropic Agents 17
Totale 16.213
Categoria #
all - tutte 49.784
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.784


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021906 0 0 0 0 0 130 83 95 100 180 113 205
2021/20221.134 99 102 114 93 53 108 64 42 56 105 99 199
2022/20231.826 207 482 205 183 169 229 37 85 102 35 57 35
2023/20241.181 47 45 67 73 110 267 212 68 73 33 69 117
2024/20253.063 125 301 358 144 227 143 155 129 257 476 225 523
2025/20263.345 767 355 483 691 853 196 0 0 0 0 0 0
Totale 16.213